No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
PFE241220P29500
- 3.90
- 0.000.00%
15min DelayTrading Dec 13 15:58 ET
0.00High0.00Low
0.00Open3.90Pre Close0 Volume58 Open Interest29.50Strike Price0.00Turnover135.27%IV0.27%PremiumDec 20, 2024Expiry Date3.83Intrinsic Value100Multiplier4DDays to Expiry0.07Extrinsic Value100Contract SizeAmericanOptions Type-0.8109Delta0.0728Gamma6.67Leverage Ratio-0.1172Theta-0.0025Rho-5.41Eff Leverage0.0075Vega
Intraday
- 5D
- Daily
News
Goldman Sachs Maintains Pfizer(PFE.US) With Buy Rating, Maintains Target Price $33
Jefferies Maintains Pfizer(PFE.US) With Buy Rating, Maintains Target Price $33
Jefferies Sticks to Their Buy Rating for Pfizer (PFE)
Wells Fargo Adjusts Price Target on Pfizer to $27 From $30
Pfizer (NYSE:PFE) Is Increasing Its Dividend To $0.43
Promise Bio Emerges From Stealth With $8.3M Seed Investment to Transform Precision Medicine for Immune-Mediated Diseases